PMC:2944646 / 1075-1516 JSONTXT

{"project":"TEST0","denotations":[{"id":"20877425-178-186-198847","span":{"begin":178,"end":182},"obj":"[\"10338102\"]"},{"id":"20877425-193-201-198848","span":{"begin":193,"end":197},"obj":"[\"16007238\"]"},{"id":"20877425-235-243-198849","span":{"begin":435,"end":439},"obj":"[\"12006732\"]"}],"text":"Piracetam, the prototype of the so-called “nootropic” drugs is used in many countries to treat cognitive impairment in aging, brain injuries, as well as dementia (Muller et al., 1999; Winblad, 2005). A recent meta-analysis of all available (published and not published) clinical studies provided compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment (Waegemans et al., 2002)."}

{"project":"0_colil","denotations":[{"id":"20877425-10338102-198847","span":{"begin":178,"end":182},"obj":"10338102"},{"id":"20877425-16007238-198848","span":{"begin":193,"end":197},"obj":"16007238"},{"id":"20877425-12006732-198849","span":{"begin":435,"end":439},"obj":"12006732"}],"text":"Piracetam, the prototype of the so-called “nootropic” drugs is used in many countries to treat cognitive impairment in aging, brain injuries, as well as dementia (Muller et al., 1999; Winblad, 2005). A recent meta-analysis of all available (published and not published) clinical studies provided compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment (Waegemans et al., 2002)."}

{"project":"2_test","denotations":[{"id":"20877425-10338102-38147940","span":{"begin":178,"end":182},"obj":"10338102"},{"id":"20877425-16007238-38147941","span":{"begin":193,"end":197},"obj":"16007238"},{"id":"20877425-12006732-38147942","span":{"begin":435,"end":439},"obj":"12006732"}],"text":"Piracetam, the prototype of the so-called “nootropic” drugs is used in many countries to treat cognitive impairment in aging, brain injuries, as well as dementia (Muller et al., 1999; Winblad, 2005). A recent meta-analysis of all available (published and not published) clinical studies provided compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment (Waegemans et al., 2002)."}